Patents by Inventor Robert Young

Robert Young has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oxazolidin-2-one and thiazolidin-2-one derivatives for use as EPreceptor agonists in the treatment of glaucoma
    Patent number: 7109223
    Abstract: This invention relates to potent selective agonists of the EP4 subtype of prostaglandin E2 receptors, their use or a formulation thereof in the treatment of glaucoma and other conditions which are related to elevated intraocular pressure in the eye of a patient. This invention further relates to the use of the compounds of this invention for mediating the bone modeling and remodeling processes of the osteoblasts and osteoclasts.
    Type: Grant
    Filed: August 25, 2003
    Date of Patent: September 19, 2006
    Assignee: Merck & Co. Inc.
    Inventors: Yongxin Han, John Colucci, Xavier Billot, Marie-Claire Wilson, Robert Young
  • Lossless manipulation of media objects
    Publication number: 20060187241
    Abstract: An original media object, such as an image, is edited without loss of the data comprising the media object. Changes applied to the media object are defined by metadata associated with the media object. For example, metadata define the cropping of an original JPEG image without loss of the original image. The metadata from a previous editing session can be used to further revising a change to the media object. Preferably, the metadata are stored as a stream in a substorage of an object linking and embedding (OLE) file. For display purposes, and for ease of modification, an edited version of the media object is stored as another stream of data in the substorage of the OLE file. The edited version of the media object is preferably compressed and serves as an intermediate object for faster display during editing and as a surrogate if the original media object is unavailable.
    Type: Application
    Filed: April 17, 2006
    Publication date: August 24, 2006
    Applicant: Microsoft Corporation
    Inventors: Sabrina Boler, Karen Baker, Robert Gruhl, Robert Young, Thomas Getzinger
  • Banded door sill base and door sill assembly, and method of forming same
    Publication number: 20060174545
    Abstract: The present invention is directed to a banded doorsill base for disposition between a pair of doorjambs of a door frame. The doorsill base includes an elongate central portion formed from a polymeric material having a first coefficient of linear expansion, and first and second wooden strips bonded to and extending along opposite sides of the central portion for constraining the central portion and preventing linear expansion thereof. The first and second strips are formed from a material having a second coefficient of linear expansion less than the first coefficient. The first and second strips substantially prevent linear expansion of the central portion. The present invention also relates to a method of forming the banded doorsill base, and to a doorsill assembly having a banded doorsill base.
    Type: Application
    Filed: February 9, 2005
    Publication date: August 10, 2006
    Inventor: Robert Young
  • 3-Sulfonylamino-pyrrolindine -2- one derivatives as inhibitors of factor xa
    Publication number: 20060178419
    Abstract: The invention relates to compounds of formula (I): wherein substituents are as defined.
    Type: Application
    Filed: June 17, 2004
    Publication date: August 10, 2006
    Applicant: GLAXO GROUP LIMITED
    Inventors: Alan Borthwick, John Harling, Wendy Irving, Savvas Kleanthous, Nigel Watson, Robert Young
  • Pyrrolydin-2-one derivatives as inhibitors of thrombin and factor xa
    Publication number: 20060166985
    Abstract: The invention relates to novel chemical compounds, pharmaceutically acceptable derivatives thereof, processes for their preparation, pharmaceutical compositions containing them, and to their use in medicine, particularly use in the amelioration of a clinical condition for which a thrombin inhibitor is indicated.
    Type: Application
    Filed: December 4, 2003
    Publication date: July 27, 2006
    Inventors: Alan Borthwick, Chuen Chan, Henry Kelly, Simon Peace, Stefan Senger, Gita Shah, Stefan Smith, Steven Smith, Nigel Watson, Robert West, Robert Young
  • Pyrrolidine -2-ones as factor xa inhibitors
    Publication number: 20060167079
    Abstract: The invention relates to compounds of formula (I): wherein substituents are as defined.
    Type: Application
    Filed: July 17, 2004
    Publication date: July 27, 2006
    Inventors: Alan Borthwick, Henry Kelly, Nigel Watson, Robert Young
  • Ep4 receptor agonists
    Publication number: 20060167081
    Abstract: This invention relates to potent selective agonists of the EP, subtype of prostaglandin E2 receptors, their use or a formulation thereof in the treatment of glaucoma and other conditions which are related to elevated intraocular pressure in the eye of a patient. This invention further relates to the use of the compounds of this invention for mediating the bone modeling and remodeling processes of the osteoblasts and osteoclasts.
    Type: Application
    Filed: October 23, 2003
    Publication date: July 27, 2006
    Inventors: Xavier Billot, Jean-Luc Beaunard, Yongxin Han, Robert Young, John Colucci, Mario Girard, Marie-Claire Wilson
  • Chemical compounds
    Publication number: 20060160886
    Abstract: The invention relates to compounds of formula (Ic) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Application
    Filed: March 17, 2006
    Publication date: July 20, 2006
    Inventors: Chuen Chan, Julie Hamblin, Henry Kelly, Nigel King, Andrew Mason, Vipulkumar Patel, Stefan Senger, Gita Shah, Nigel Watson, Helen Weston, Caroline Whitworth, Robert Young
  • Chemical compounds
    Publication number: 20060160885
    Abstract: The invention relates to compounds of formula (Ic) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Application
    Filed: March 17, 2006
    Publication date: July 20, 2006
    Inventors: Chuen Chan, Julie Hamblin, Henry Kelly, Nigel King, Andrew Mason, Vipulkumar Patel, Stefan Senger, Gita Shah, Nigel Watson, Helen Weston, Caroline Whitworth, Robert Young
  • Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma
    Publication number: 20060154899
    Abstract: This invention relates to potent selective agonists of the EP4 subtype of prostaglandin E2 receptors, their use or a formulation thereof in the treatment of glaucoma and other conditions which are related to elevated intraocular pressure in the eye of a patient. This invention further relates to the use of the compounds of this invention for mediating the bone modeling and remodeling processes of the osteoblasts and osteoclasts.
    Type: Application
    Filed: August 25, 2003
    Publication date: July 13, 2006
    Inventors: Yongxin Han, John Colucci, Xavier Billot, Marie-Claire Wilson, Robert Young
  • Crystalline form
    Publication number: 20060124049
    Abstract: The present invention includes (E)-2-(5-Chlorothien-2-yl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl)ethenesulfonamide in substantially crystalline form, pharmaceutical formulations thereof, processes for preparing it, and its use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Application
    Filed: December 4, 2003
    Publication date: June 15, 2006
    Inventors: Philip Dell Orco, Henry Kelly, Gita Shah, Nigel Watson, Robert Young
  • Method for preparing solid precursor tray for use in solid precursor evaporation system
    Publication number: 20060115593
    Abstract: In a solid precursor evaporation system configured for use in a thin film deposition system, such as thermal chemical vapor deposition (TCVD), a method for preparing one or more trays of solid precursor is described. The solid precursor may be formed on a coating substrate, such as a tray, using one or more of dipping techniques, spin-on techniques, and sintering techniques.
    Type: Application
    Filed: December 9, 2004
    Publication date: June 1, 2006
    Inventors: Kenji Suzuki, Emmanuel Guidotti, Gerrit Leusink, Masamichi Hara, Daisuke Kuroiwa, Sandra Malhotra, Fenton McFeely, Robert Young
  • Circuit board having an overlapping Via
    Publication number: 20060060380
    Abstract: A printed circuit board (100) includes a first BGA landing pad (102) having a first clearance zone (106) and a second BGA landing pad (104) having a second clearance zone (108). A via (110), overlaps the first clearance zone and the second clearance zone such that the first BGA landing pad and the second BGA landing pad are electrically coupled to the via.
    Type: Application
    Filed: September 23, 2004
    Publication date: March 23, 2006
    Inventors: Matthew Meyer, Jesse Chai, Paul Roosen, Robert Young
  • Rot resistant casing and method of making a rot restistant casing
    Publication number: 20060059798
    Abstract: An wood rot resistant assembly comprises a vertical wooden member having an exposed end grain. At least two buttons extend from the end grain. A sill assembly defines a horizontal base plane. The sill assembly extends perpendicular to the vertical member. The buttons elevate the vertical member end grain above the horizontal base plane.
    Type: Application
    Filed: September 23, 2004
    Publication date: March 23, 2006
    Inventor: Robert Young
  • Nitric oxide releasing selective cyclooxygenase-2 inhibitors
    Publication number: 20060058363
    Abstract: The invention encompasses novel compounds of Formula (I) and Formula (II), which are nitric oxide-releasing prodrugs useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions and methods for treatment of cyclooxygenase-2 mediated diseases comprising the use of compounds of Formula (I) or Formula (II). The above compounds may be used as a combination therapy with low-dose aspirin to treat chronic cyclooxygenase-2 mediated diseases or conditions while simultaneously reducing the risk of thrombotic cardiovascular events.
    Type: Application
    Filed: October 21, 2003
    Publication date: March 16, 2006
    Inventors: Zhaoyin Wang, Robert Young, Robert Zamboni
  • SYSTEM AND METHOD FOR COLLECTING DIAGNOSIS AND PRESCRIPTION DRUG INFORMATION
    Publication number: 20050288966
    Abstract: A system for the capture, management or use of patient medical and prescription data is disclosed. In some illustrative embodiments, the system includes: a computer system including at least one server computer and at least one physician computer in communication with said at least one server over a network, such as the Internet; wherein said at least one server computer includes a database of drug side effects, interactions or contraindications, which are accessible via said at least one physician computer via a graphical user interface.
    Type: Application
    Filed: December 27, 2004
    Publication date: December 29, 2005
    Inventor: Robert YOUNG
  • Desiccant container and method of manufacture
    Publication number: 20050274259
    Abstract: A desiccant container (10) includes a cylindrical body (12) having a first end (14) and an opposed second end (16). The cylindrical body (12) defines a desiccant chamber (18) within the cylindrical body (12) for holding the desiccant material within the chamber (18) between the first and second ends (14, 16). The cylindrical body (12) is made of a flexible, gas permeable, liquid impermeable material. A first disk (20) is secured adjacent the first end (14), and a second disk (22) secured adjacent the second end (16) to facilitate closing of the ends (14, 16) and to support maintenance of a cylindrical shape of the container (10) during usage of the desiccant container (10) in high-speed automated packaging machinery.
    Type: Application
    Filed: June 10, 2005
    Publication date: December 15, 2005
    Inventors: Robert Young, Stephen Derby
  • Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
    Publication number: 20050261245
    Abstract: The invention encompasses novel compounds of Formula I, which are nitric oxide-releasing prodrugs of diaryl-2-(5H) furanones useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions and methods for treatment of cyclooxygenase-2 mediated diseases comprising the use of compounds of Formula I. The above compounds may be used as a combination therapy with low-dose aspirin to treat chronic cyclooxygenase-2 mediated diseases or conditions while simultaneously reducing the risk of thrombotic cardiovascular events.
    Type: Application
    Filed: July 24, 2003
    Publication date: November 24, 2005
    Inventors: Carl Berthelette, Nicholas Lachance, Lianhai Li, Claudio Sturino, Zhaoyin Wang, Robert Young, Claude Dufresne
  • 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the teatment of eye diseases such as glaucoma
    Publication number: 20050239872
    Abstract: This invention relates to potent selective agonists of the EP4 subtype of prostaglandin E2 receptors of formula (1), their use or a formulation thereof in the treatment of glaucoma and other conditions which are related to elevated intraocular pressure in the eye of the patient.
    Type: Application
    Filed: June 2, 2003
    Publication date: October 27, 2005
    Inventors: Xavier Billot, Robert Young, Yongxin Han
  • EP4 receptor agonist, compositions and methods thereof
    Publication number: 20050227969
    Abstract: This invention relates to potent selective agonists of the EP4 subtype of prostaglandin E2 receptors, their use or a formulation thereof in the treatment of glaucoma and other conditions, which are related to elevated intraocular pressure in the eye of a patient. This invention further relates to the use of the compounds of this invention for mediating the bone modeling and remodeling processes of the osteoblasts and osteoclasts.
    Type: Application
    Filed: June 7, 2005
    Publication date: October 13, 2005
    Inventors: Xavier Billot, John Colucci, Yongxin Han, Marie-Claire Wilson, Robert Young